Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial

PURPOSE: Fatigue is one of the most common symptoms experienced by patients with cancer. This trial was developed to evaluate the efficacy of long-acting methylphenidate for improving cancer-related fatigue and to assess its toxicities. PATIENTS AND METHODS: Adults with cancer were randomly assigned...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moraska, Amanda R., Sood, Amit, Dakhil, Shaker R., Sloan, Jeff A., Barton, Debra, Atherton, Pamela J., Suh, Jason J., Griffin, Patricia C., Johnson, David B., Ali, Aneela, Silberstein, Peter T., Duane, Steven F., Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917307/
https://ncbi.nlm.nih.gov/pubmed/20625123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.28.1444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados